Invention Grant
- Patent Title: Triterpene saponin analogues
-
Application No.: US16827220Application Date: 2020-03-23
-
Publication No.: US10906926B2Publication Date: 2021-02-02
- Inventor: David Y. Gin , Eric Chea , Alberto Fernandez-Tejada , Jeffrey Gardner , Jason Lewis , Philip Livingston , J. Tyler Martin , Lars Nordstroem , Naga Vara Kishore Pillarsetty , Govind Ragupathi , Derek Tan
- Applicant: ADJUVANCE TECHNOLOGIES, INC. , MEMORIAL SLOAN KETTERING CANCER CENTER , Mary S. Gin
- Applicant Address: US NE Lincoln; US NY New York; US NY Pelham
- Assignee: ADJUVANCE TECHNOLOGIES, INC.,MEMORIAL SLOAN KETTERING CANCER CENTER,Mary S. Gin
- Current Assignee: ADJUVANCE TECHNOLOGIES, INC.,MEMORIAL SLOAN KETTERING CANCER CENTER,Mary S. Gin
- Current Assignee Address: US NE Lincoln; US NY New York; US NY Pelham
- Agency: Strain & Strain PLLC
- Agent Paul D. Strain, Esq.
- Main IPC: C07H1/00
- IPC: C07H1/00 ; C07H13/04 ; C07H13/06 ; C07H13/08 ; C07J63/00 ; A61P31/04 ; A61K31/7024 ; A61K39/08 ; A61K39/02 ; A61K39/39 ; A61K39/10 ; A61K39/00

Abstract:
The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.
Public/Granted literature
- US20200239509A1 TRITERPENE SAPONIN ANALOGUES Public/Granted day:2020-07-30
Information query